Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-29 7:00 pm Sale | 2024-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund L.P. | 2,108,958 11.960% | -200,000 (-8.66%) | Filing History |
| 2024-12-12 5:00 pm Sale | 2024-12-12 | 13G | Exagen Inc. XGN | Hunt Holdings Limited Partnership | 829,280 4.700% | -182,044 (-18.00%) | Filing History |
| 2024-02-14 2:42 pm Purchase | 2023-12-31 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 1,153,488 6.800% | 282,307 (+32.41%) | Filing History |
| 2024-02-14 07:12 am Purchase | 2023-12-31 | 13G | Exagen Inc. XGN | RTW INVESTMENTS LP | 1,504,602 8.800% | 140,266 (+10.28%) | Filing History |
| 2024-02-13 4:35 pm Sale | 2023-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 669,684 3.900% | -184,358 (-21.59%) | Filing History |
| 2024-02-13 06:13 am Purchase | 2023-12-31 | 13G | Exagen Inc. XGN | TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,867,116 10.700% | 9,167 (+0.49%) | Filing History |
| 2024-02-09 5:10 pm Sale | 2024-02-09 | 13G | Exagen Inc. XGN | WASATCH ADVISORS LP | 850,308 4.900% | -150,253 (-15.02%) | Filing History |
| 2024-02-02 3:16 pm Sale | 2023-12-29 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 898,630 5.270% | -67,392 (-6.98%) | Filing History |
| 2024-01-22 4:15 pm Unchanged | 2023-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund L.P. | 2,308,958 13.550% | 0 (Unchanged) | Filing History |
| 2023-02-14 10:01 am Purchase | 2022-12-31 | 13G | Exagen Inc. XGN | RTW INVESTMENTS LP | 1,364,336 8.400% | 542,922 (+66.10%) | Filing History |
| 2023-02-13 3:47 pm Purchase | 2022-12-31 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 871,181 5.300% | 37,876 (+4.55%) | Filing History |
| 2023-02-13 10:58 am Sale | 2022-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management LLC | 854,042 5.200% | -4,525 (-0.53%) | Filing History |
| 2023-02-09 5:03 pm Sale | 2023-02-09 | 13G | Exagen Inc. XGN | WASATCH ADVISORS LP | 1,000,561 6.100% | -105,199 (-9.51%) | Filing History |
| 2023-02-07 12:54 pm Sale | 2022-12-31 | 13G | Exagen Inc. XGN | TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,857,949 11.380% | -10,190 (-0.55%) | Filing History |
| 2023-02-06 12:23 pm Sale | 2022-12-31 | 13G | Exagen Inc. XGN | BANK OF MONTREAL BMO | 0 0.000% | -1,015,612 (Position Closed) | Filing History |
| 2023-02-02 4:16 pm Unchanged | 2022-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund L.P. | 2,308,958 14.150% | 0 (Unchanged) | Filing History |
| 2023-01-23 5:13 pm Sale | 2022-12-30 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 966,022 5.920% | -418,609 (-30.23%) | Filing History |
| 2022-11-23 2:40 pm Purchase | 2022-11-14 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 833,305 5.100% | 833,305 (New Position) | Filing History |
| 2022-02-15 09:48 am Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | BANK OF MONTREAL BMO | 1,015,612 6.300% | 1,015,612 (New Position) | Filing History |
| 2022-02-14 1:10 pm Sale | 2021-12-31 | 13G | Exagen Inc. XGN | TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,868,139 11.560% | -22,383 (-1.18%) | Filing History |